October 27, 2020 12:40 pm US Officials Cut Short COVID-19 Antibody Trial U.S. regulators have ended one of Eli Lilly’s COVID-19 antibody trials early after data suggested the drug was “unlikely to help” coronavirus patients recover. US & World Videos 0:40 Watch: Police dog tracks and finds missing 85-year-old woman in Colorado 2:19 11-year-old celebrates teachers with appreciation snack cart 1:19 Met Gala 2024 after party looks: Cardi B, Lana Del Rey, EmRata 6:22 Craig Melvin compares ‘TODAY' crew to NASCAR 1:02 Judge indefinitely delays Trump's classified documents criminal trial